| Lashonda Lucas Scott, MS | |
|
1200 1st St Ne Fl E9, Washington, DC 20002-3361 | |
| (202) 442-5026 | |
| Not Available |
| Full Name | Lashonda Lucas Scott |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1200 1st St Ne Fl E9, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174045041 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lashonda Lucas Scott, MS 1200 First Street N.e., 9th Floor, Washington, DC 20002 Ph: () - | Lashonda Lucas Scott, MS 1200 1st St Ne Fl E9, Washington, DC 20002-3361 Ph: (202) 442-5026 |
News Archive
A scientist from the Florida campus of The Scripps Research Institute has been awarded just over $1 million from the National Institutes of Health to develop a range of new tests that could lead to new treatments for a number of stress-associated and degenerative disorders of advancing age.
Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent tumors of the head and neck.
Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) released unaudited preliminary financial results for the first quarter of fiscal year 2015.
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.
An article published in the Health Affairs December issue is the first ever comprehensive analysis to investigate the Affordable Care Act's (ACA) Essential Health Benefit (EHB) as it relates to children. The study found that the EHB has resulted in a state-by-state patchwork of coverage for children and adolescents that has significant exclusions, particularly for children with developmental disabilities and other special health care needs.
› Verified 3 days ago
Sheryl Jacob Desbordes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-4424 | |
Karen Garrido-nag, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Speech, Language And Hearing Sciences, Washington, DC 20002 Phone: 202-448-6964 Fax: 202-448-5324 | |
Voicetrainer, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Pennsylvania Ave Nw, Suite 300, Washington, DC 20006 Phone: 202-580-6646 Fax: 202-580-6559 | |
Samantha Wasilus, M.S CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4880 Macarthur Blvd Nw, Washington, DC 20007 Phone: 202-333-1403 Fax: 202-333-1404 | |
Tahera Sparks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Connecticut Ave Nw # 100, Washington, DC 20008 Phone: 202-525-1641 | |
Sydney Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Massachusetts Ave Ne Ste C9, Washington, DC 20002 Phone: 202-544-5469 | |
Joyce Doyle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3009 5th St Se, Washington, DC 20032 Phone: 571-221-2840 |